We are conscientious in maintaining our objectivity and ensuring that patient priorities are the focus of our work, especially when working with companies.
We work with pharmaceutical companies and are very grateful for their support and the difference working in partnership can make for our community. We will always put patients at the heart of everything we do to ensure we’re able to best serve people living with IBD. As such, we are committed to working collaboratively with pharmaceutical companies, alongside other stakeholders involved in IBD, to improve patient outcomes.
To ensure we maintain our independence, we provide information but never recommend any one treatment or medication in our resources or communications. To safeguard Crohn’s & Colitis UK’s independence, funding from pharmaceutical and medical device companies will not exceed fifteen percent (15%) of the charity’s total annual income.
We are committed to working in a transparent, consistent and fair way when working with industry to maintain our integrity and reputation within the charity and health sectors.